Ting He

Transition from inflammation to proliferation: a critical step during wound healing

Regulation of microRNA function in animals

Expanding the Biologist’s Toolkit with CRISPR-Cas9

Epigenetic regulation of key vascular genes and growth factors

Synthesizing AND gate genetic circuits based on CRISPR-Cas9 for identification of bladder cancer cells

PDL1 Regulation by p53 via miR-34

Functional Characterization of SAMD9, a Protein Deficient in Normophosphatemic Familial Tumoral Calcinosis

Regulation and Function of the PD-L1 Checkpoint

MicroRNA therapeutics: towards a new era for the management of cancer and other diseases

Immune checkpoint inhibitors: recent progress and potential biomarkers

MicroRNA

Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine

Epithelial Mesenchymal Transition in Tumor Metastasis

Nanotechnology for Multimodal Synergistic Cancer Therapy

Chemotherapy induces enrichment of CD47 ⁺ /CD73 ⁺ /PDL1 ⁺ immune evasive triple-negative breast cancer cells

C7L Family of Poxvirus Host Range Genes Inhibits Antiviral Activities Induced by Type I Interferons and Interferon Regulatory Factor 1

Double strand RNA‐guided endogeneous E‐cadherin up‐regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo

Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549

Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemia